4-[-2-[[5-METHYL-1-(2-NAPHTALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE HYDROCHLORIDE AMORPHOUS SOLID FORMS - Patent 2603495

(19)

(11)

EP 2 603 495 A1

(12)

(43)	Date of publication:
	19.06.2013 Bulletin 2013/25

(21)	Application number: 11740675.1

(22)	Date of filing: 08.08.2011

(51)

International Patent Classification (IPC):

C07D 231/22^(2006.01)
A61P 25/00^(2006.01)

A61P 25/16^(2006.01)
A61K 31/4152^(2006.01)

(86)	International application number:
	PCT/EP2011/063583

(87)	International publication number:
	WO 2012/019984 (16.02.2012 Gazette 2012/07)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME

(30)

Priority:

09.08.2010 EP 10382225

(71)	Applicant: Laboratorios del. Dr. Esteve, S.A.
	08041 Barcelona (ES)

(72)	Inventors:
	BENET BUCHHOLZ, Jordi E-43893 Altafulla-Tarragona (ES) PUIG FERNANDEZ, Laura E-50019 Zaragoza (ES)

(74)	Representative: ABG Patentes, S.L.
	Avenida de Burgos, 16D Edificio Euromor 28036 Madrid 28036 Madrid (ES)

(54)	4-[-2-[[5-METHYL-1-(2-NAPHTALENYL)-1H-PYRAZOL-3-YL]OXY]ETHYL]MORPHOLINE HYDROCHLORIDE AMORPHOUS SOLID FORMS